scPharmaceuticals to Announce Fourth Quarter and Full Year 2024 Financial Results on Wednesday, March 19, 2025
scPharmaceuticals (Nasdaq: SCPH), a pharmaceutical company focused on cardiorenal healthcare innovations, has scheduled its Fourth Quarter and Full Year 2024 Financial Results announcement for Wednesday, March 19, 2025. The company will host a conference call and audio webcast at 4:30 p.m. ET following market close.
Management will present financial results and provide a business update during the call. Investors and interested parties can access the event through a direct registration link, with both live webcast and replay options available on the company's website under the Investor Relations section.
scPharmaceuticals (Nasdaq: SCPH), un'azienda farmaceutica focalizzata sulle innovazioni nel settore della salute cardiorenale, ha programmato l'annuncio dei suoi Risultati Finanziari del Quarto Trimestre e dell'Anno Completo 2024 per mercoledì 19 marzo 2025. L'azienda ospiterà una conferenza telefonica e una trasmissione audio in diretta alle 16:30 ET dopo la chiusura del mercato.
La direzione presenterà i risultati finanziari e fornirà un aggiornamento sull'azienda durante la chiamata. Gli investitori e le parti interessate possono accedere all'evento tramite un link di registrazione diretto, con opzioni di trasmissione in diretta e di riproduzione disponibili sul sito web dell'azienda nella sezione Relazioni con gli Investitori.
scPharmaceuticals (Nasdaq: SCPH), una compañía farmacéutica enfocada en innovaciones para la salud cardiorenal, ha programado el anuncio de sus Resultados Financieros del Cuarto Trimestre y del Año Completo 2024 para miércoles, 19 de marzo de 2025. La empresa llevará a cabo una llamada de conferencia y una transmisión de audio en vivo a las 4:30 p.m. ET después del cierre del mercado.
La dirección presentará los resultados financieros y proporcionará una actualización del negocio durante la llamada. Los inversores y partes interesadas pueden acceder al evento a través de un enlace de registro directo, con opciones de transmisión en vivo y repetición disponibles en el sitio web de la empresa en la sección de Relaciones con Inversores.
scPharmaceuticals (Nasdaq: SCPH)는 심장 신장 건강 혁신에 중점을 둔 제약 회사로, 2024년 4분기 및 연간 재무 결과 발표를 2025년 3월 19일 수요일로 예정하고 있습니다. 회사는 시장 종료 후 오후 4시 30분 ET에 회의 전화 및 오디오 웹캐스트를 개최합니다.
경영진은 통화 중 재무 결과를 발표하고 비즈니스 업데이트를 제공할 것입니다. 투자자 및 이해관계자는 직접 등록 링크를 통해 이벤트에 접근할 수 있으며, 회사 웹사이트의 투자자 관계 섹션에서 라이브 웹캐스트 및 재생 옵션을 이용할 수 있습니다.
scPharmaceuticals (Nasdaq: SCPH), une entreprise pharmaceutique axée sur les innovations en santé cardiorénale, a programmé l'annonce de ses Résultats Financiers du Quatrième Trimestre et de l'Année Complète 2024 pour mercredi 19 mars 2025. L'entreprise organisera une conférence téléphonique et un webinaire audio à 16h30 ET après la fermeture du marché.
La direction présentera les résultats financiers et fournira une mise à jour sur l'entreprise lors de l'appel. Les investisseurs et les parties intéressées peuvent accéder à l'événement via un lien d'inscription direct, avec des options de webinaire en direct et de rediffusion disponibles sur le site web de l'entreprise dans la section Relations avec les Investisseurs.
scPharmaceuticals (Nasdaq: SCPH), ein Pharmaunternehmen, das sich auf Innovationen im Bereich der kardiovaskulären Gesundheit konzentriert, hat die Bekanntgabe seiner Finanzergebnisse für das vierte Quartal und das Gesamtjahr 2024 für Mittwoch, den 19. März 2025 angesetzt. Das Unternehmen wird nach Börsenschluss um 16:30 Uhr ET eine Telefonkonferenz und einen Audio-Webcast veranstalten.
Das Management wird während des Anrufs die Finanzergebnisse präsentieren und ein Update zum Geschäft geben. Investoren und Interessierte können über einen direkten Registrierungslink auf die Veranstaltung zugreifen, wobei sowohl Live-Webcast- als auch Wiederholungsoptionen auf der Website des Unternehmens im Bereich Investor Relations verfügbar sind.
- None.
- None.
Management to host conference call and webcast, after-market on March 19, 2025, at 4:30 p.m. ET
BURLINGTON, Mass., March 12, 2025 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company committed to revolutionizing cardiorenal healthcare through patient-centric innovations, today announced that scPharmaceuticals management will host a conference call and audio webcast at 4:30 p.m. ET on Wednesday, March 19, 2025, to discuss the financial results for the fourth quarter and full year 2024, and provide a business update.
Registration and access for the conference call can be completed through this direct registration link.
The live webcast and replay of the conference call can be accessed here or under “News & Events” in the Investor Relations section of the Company’s website, www.scpharmaceuticals.com.
About scPharmaceuticals
At scPharmaceuticals, we are powered by passion, driven by patient care. Our Mission is focused on advancing cardiorenal care through innovative, integrated treatments that address unmet patient needs.
Our goal is to become the foremost advocate for patient-centric cardiorenal care, driving global health improvements through specialized, multidisciplinary approaches. scPharmaceuticals is expanding its reach, offering integrated therapies and products that address diverse healthcare needs and potentially improve the lives of our patients. scPharmaceuticals is headquartered in Burlington, MA. For more information, please visit www.scPharmaceuticals.com.
Katherine Miranda
scPharmaceuticals Inc., 781-301-6869
kmiranda@scpharma.com
Investors:
Nick Colangelo
Gilmartin Group, 339-225-1047
Nick@GilmartinIR.com
FAQ
When will SCPH release its Q4 and Full Year 2024 earnings?
What time is SCPH's Q4 2024 earnings call scheduled for?
How can investors access SCPH's Q4 2024 earnings call?
What will be discussed during SCPH's upcoming earnings call?
